Vineeta Agarwala
General partner at Andreessen Horowitz. Discusses the transformative role of AI agents in healthcare.
Top 5 podcasts with Vineeta Agarwala
Ranked by the Snipd community
32 snips
Jul 24, 2025 • 3h 29min
Google Doubles Down on Cloud AI, Hulk Hogan Passes Away at 71, Hill and Valley Forum Reactions | Casey Neistat, Chris Samra, Zak Kukoff, Vineeta Agarwala, Micky Malka, Alex Hawkinson
Vineeta Agarwala, a general partner at Andreessen Horowitz, unveils how AI agents are set to revolutionize healthcare, improving drug development and patient care. Micky Malka, founder of Ribbit Capital, shares insights on enhancing financial accessibility and trust. Casey Neistat discusses engaging retro technology through ModRetro's M64. Zak Kukoff dives into the backlash against Trevor Milton's controversial interview. Meanwhile, Chris Samra introduces Waves camera glasses, merging AI with consumer tech, and Alex Hawkinson reveals how BrightAI is transforming infrastructure management with real-time solutions.
11 snips
May 4, 2023 • 48min
Reengineering Healthcare and Medicine with Technology with Vineeta Agarwala
This is a crossover episode with The Bioverge Podcast, hosted by Neil Littman. Neil is joined by Vineeta Agarwala, general partner at a16z Bio + Health. Together, they chat about Vineeta's dual role as a clinician and investor, the adoption curve of digital therapeutics, how Vineeta thinks about platforms and a modular, engineering-driven approach to biotech, and much more.
May 21, 2024 • 57min
The Intersection of Biotech x High Tech with Vineeta Agarwala
Vineeta Agarwala, MD, PhD, discusses AI for drug discovery and her work as a physician. Topics include AI in drug discovery, biotech acquisitions in Seattle, tech-driven innovation in biotech investments, compassionate care in biotech, impact of AI in healthcare, and future of drug discovery in a high-tech world.
Sep 20, 2021 • 56min
Uncontrolled Spread: Science, Policy, Institutions, Infrastructure
Scott Gottlieb, former head of the FDA and author of 'Uncontrolled Spread,' dives into the lessons learned from the COVID-19 pandemic. He discusses the critical role technology, particularly mRNA vaccine development, played in pandemic response and highlights failures in regulatory translation of science to policy. Joining him are Marc Andreessen, a prominent venture capitalist, and Vineeta Agarwala, a bio expert. They explore the need for improved genomic surveillance, private sector involvement in health infrastructure, and the ethical dilemmas of challenge trials for future preparedness.
May 1, 2024 • 57min
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
Vineeta Agarwala, a general partner at A16Z's Bio & Health fund, discusses AI's impact on drug discovery. Topics include AI automating tasks, learning from negative data, and the hype around AI in healthcare. She emphasizes the importance of small startups in curating data for AI, the necessity of patience in biotech investments, and the future of collaborative learning in drug discovery.
